Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

932-highlights-from-the-13th-african-continental-meeting-of-the-international-society-of-paediatric-oncology-siop-6-9-march-2019-cairo-egypt

Conference Report: Highlights from the 13th African Continental Meeting of the International Society of Paediatric Oncology (SIOP), 6–9 March 2019, Cairo, Egypt

Elhamy Rifky Khalek, Glenn M Afungchwi, Mohamed El Beltagy, Ndagire Mariam, Hoda Zaki, Trijn Israels, Elizabeth Molyneux, Scott C Howard, Catherine Patte, Judy Schoeman, Elena Ladas, Mohamed S Zaghloul, Yasser S ElDeen, Soha Ahmed, Sherif Kamal, Eric Bouffet, Kathy Pritchard-Jones, Laila Hessissen

28 May 2019

https://doi.org/10.3332/ecancer.2019.932

Abstract | Full Article | PDF

921-assessing-the-tolerability-and-efficacy-of-first-line-chemotherapy-in-elderly-patients-with-metastatic-her2-ve-breast-cancer

Clinical Study: Assessing the tolerability and efficacy of first-line chemotherapy in elderly patients with metastatic HER2−ve breast cancer

Thomas Wilson, Claire Dyke, Hannah Reed, Zoe Hudson, Timothy Robinson, Paola Di Nardo

3 Apr 2019

https://doi.org/10.3332/ecancer.2019.921

Abstract | Full Article | PDF

920-precision-oncology-in-latin-america-current-situation-challenges-and-perspectives

Policy: Precision oncology in Latin America: current situation, challenges and perspectives

Ali Calderon-Aparicio, Andrea Orue

3 Apr 2019

https://doi.org/10.3332/ecancer.2019.920

Abstract | Full Article | PDF | Spanish

898-access-to-high-cost-drugs-for-advanced-breast-cancer-in-latin-america-particularly-trastuzumab

Special Issue: Access to high-cost drugs for advanced breast cancer in Latin America, particularly trastuzumab

Carlos Henrique Barrios, Tomás Reinert, Gustavo Werutsky

22 Jan 2019

https://doi.org/10.3332/ecancer.2019.898

Abstract | Full Article | PDF | Spanish

895-locally-advanced-breast-cancer-in-brazil-current-status-and-future-perspectives

Special Issue: Locally advanced breast cancer in Brazil: current status and future perspectives

Gustavo Werutsky, Paulo Nunes, Carlos Barrios

22 Jan 2019

https://doi.org/10.3332/ecancer.2019.895

Abstract | Full Article | PDF | Spanish

871-highlights-from-the-2018-win-symposium-25-26-june-2018-paris-designing-the-future-of-precision-oncology

Conference Report: Highlights from the 2018 WIN Symposium, 25–26 June 2018, Paris: designing the future of precision oncology

Will Davies

12 Sep 2018

https://doi.org/10.3332/ecancer.2018.871

Abstract | Full Article | PDF

848-imanagemyhealth-and-isupportmypatients-mobile-decision-support-and-health-management-apps-for-cancer-patients-and-their-doctors

Special Issue: iManageMyHealth and iSupportMyPatients: mobile decision support and health management apps for cancer patients and their doctors

Fatima Schera, Michael Schäfer, Anca Bucur, Jasper van Leeuwen, Eric Herve Ngantchjon, Norbert Graf, Haridimos Kondylakis, Lefteris Koumakis, Kostas Marias, Stephan Kiefer

11 Jul 2018

https://doi.org/10.3332/ecancer.2018.848

Abstract | Full Article | PDF

829-favourable-response-of-serum-prostate-specific-antigen-to-conjugated-oestrogen-in-castrate-resistant-prostate-cancer-in-jamaica

Short Communication: Favourable response of serum prostate-specific antigen to conjugated oestrogen in castrate-resistant prostate cancer in Jamaica

Andrew Condappa, Maxine Gossell-Williams, William Aiken

24 Apr 2018

https://doi.org/10.3332/ecancer.2018.829

Abstract | Full Article | PDF

825-evidence-on-the-cost-of-breast-cancer-drugs-is-required-for-rational-decision-making

Research: Evidence on the cost of breast cancer drugs is required for rational decision making

Anne Margreet Sofie Berghuis, Hendrik Koffijberg, Leonardus Wendelinus Mathias Marie Terstappen, Stefan Sleijfer, Maarten Joost IJzerman

16 Apr 2018

https://doi.org/10.3332/ecancer.2018.825

Abstract | Full Article | PDF

824-repurposing-drugs-in-oncology-redo-selective-pde5-inhibitors-as-anti-cancer-agents

Clinical Study: Repurposing drugs in oncology (ReDO)—selective PDE5 inhibitors as anti-cancer agents

Pan Pantziarka, Vidula Sukhatme, Sergio Crispino, Gauthier Bouche, Lydie Meheus, Vikas P Sukhatme

11 Apr 2018

https://doi.org/10.3332/ecancer.2018.824

Abstract | Full Article | PDF

More from ecancer